Andrew Hsia, MD
Retina Specialist · Montgomery, ALNPI 1316034259
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,680 of the $1,815 with a category attached, or 92.5%. Genentech, Inc. accounts for 92.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $1,681 and has fallen 96.2% since, to $64 in 2024.
Across 8 payments — averaging $226.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2K
- Bausch & Lomb Americas Inc.$58
- Genentech USA, Inc.$29
- Heidelberg Engineering, Inc.$27
- AbbVie$21
What the payments were for
- Consulting fees$1,68093%
- Food & beverage$1357%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 1 | $1,680 |
| Bausch & Lomb Americas Inc. | 3 | $58 |
| Genentech USA, Inc. | 2 | $29 |
| Heidelberg Engineering, Inc. | 1 | $27 |
| AbbVie | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TECENTRIQ$1,680
How this compares
$1,815 in reported general payments places this provider in the 80th percentile of 21 retina specialist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 67 | $2,939 |
| Brimonidine Tartrate | 20 | $2,024 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 48 | $1,035 |
| Ofloxacin | 14 | $421 |
| Dorzolamide Hcl | 22 | $382 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 38 | $319 |
| Timolol Maleate | 34 | $258 |
| Latanoprost | 18 | $168 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Montgomery
- Edward ParmaMontgomery$780
- Alan FranklinMobile$97K
- Jeffrey FullerBirmingham$15K
- Larry BrownBirmingham$4K
- Alexander TalalightHuntsville$4K
- Vikram SainiHuntsville$1K
- Tyler RowseyBirmingham$1K
- Edgar ReadyHuntsville$1K
- Cary BaxterBirmingham$1K
- Tarek PersaudHuntsville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.